Purpose
To accelerate the integration of a polio VLP vaccine into the existing whole cell pertussis pentavalent vaccines to support polio eradication and ensure the broadest possible coverage after eradication.
Grantee
Division
Global Health
Date
SEPTEMBER 2024
Region served
GLOBAL
Committed amount
$3,344,233
Grant topic
Vaccine Development
Duration (months)
36
Grantee location
Houston, Texas, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.